
Artificial Saliva Market Report 2026
Global Outlook – By Product (Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, Powder), By Distribution Channel (Supermarkets, Hypermarkets, Other Distribution Channels), By End-User (Adult, Pediatric) - Market Size, Trends, And Global Forecast 2026-2035
Artificial Saliva Market Overview
• Artificial Saliva market size has reached to $2.21 billion in 2025 • Expected to grow to $3.97 billion in 2030 at a compound annual growth rate (CAGR) of 12.2% • Growth Driver: Impact of Rising Xerostomia Prevalence on the Artificial Saliva Market • Market Trend: Adoption Of Polymer-Based Saliva Reservoir Systems To Provide Long-Lasting Moisture Relief • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Artificial Saliva Market?
Artificial saliva refers to a synthetic product designed to mimic the properties and functions of natural saliva. It is used to relieve dryness in the mouth (xerostomia) caused by various conditions such as Sjögren's syndrome, radiation therapy for cancer, or certain medications. Artificial saliva helps to moisten and lubricate the mouth, aids in chewing and swallowing, and can improve overall oral comfort. The main types of products in the artificial saliva market are oral spray, oral solution, oral liquid, dissolving tablets, gel, and powder. Oral spray is a type of formulation in a spray from, that is designed to temporarily relieve the symptoms of dry mouth (xerostomia) by providing lubrication and moisture to the oral cavity. The distribution channels encompass supermarkets, hypermarkets, and others, while the end-users include both adults and children.
What Is The Artificial Saliva Market Size and Share 2026?
The artificial saliva market size has grown rapidly in recent years. It will grow from $2.21 billion in 2025 to $2.51 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increasing prevalence of dry mouth conditions, growing use of medications causing xerostomia, expansion of cancer radiation therapies, rising awareness of oral health management, availability of over-the-counter saliva substitutes.What Is The Artificial Saliva Market Growth Forecast?
The artificial saliva market size is expected to see rapid growth in the next few years. It will grow to $3.97 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing demand from aging populations, rising focus on quality-of-life improvement therapies, expansion of pediatric-friendly formulations, growing innovation in bio-mimetic saliva products, increasing distribution through healthcare and retail channels. Major trends in the forecast period include increasing demand for xerostomia management products, rising development of alcohol-free oral formulations, growing focus on patient-friendly dosage forms, expansion of ready-to-use artificial saliva products, enhanced emphasis on oral comfort and hydration.Global Artificial Saliva Market Segmentation
1) By Product: Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, Powder 2) By Distribution Channel: Supermarkets, Hypermarkets, Other Distribution Channels 3) By End-User: Adult, Pediatric Subsegments: 1) By Oral Spray: Non-Alcoholic Oral Spray, Alcohol-Based Oral Spray 2) By Oral Solution: Ready-To-Use Oral Solution, Concentrated Oral Solution 3) By Oral Liquid: Viscous Oral Liquid, Non-Viscous Oral Liquid 4) By Dissolving Tablets: Fast-Dissolving Tablets, Slow-Dissolving Tablets 5) By Gel: High-Viscosity Gel, Low-Viscosity Gel 6) By Powder: Ready-To-Use Powder, Powder Requiring MixingWhat Is The Driver Of The Artificial Saliva Market?
The rising prevalence of dry mouth syndrome is expected to propel the growth of the artificial saliva market going forward. Dry mouth syndrome, also known as xerostomia, refers to the condition characterized by a persistent feeling of dryness in the mouth. The prevalence of dry mouth syndrome has increased partly due to an aging population and the widespread use of medications and over-the-counter drugs that can cause the xerostomia effect. Artificial saliva provides moisture to the oral tissues, helping to relieve the dry, sticky feeling commonly associated with xerostomia. For instance, in 2025, according to PubMed, the US-based National Institutes of Health, reported that the pooled prevalence of xerostomia was 38% (95% CI: 22-57%). Therefore, the rising prevalence of dry mouth syndrome is driving the growth of the artificial saliva industry.Key Players In The Global Artificial Saliva Market
Major companies operating in the artificial saliva market are Pfizer Inc., Viatris Inc., Bausch Health Companies Inc., Perrigo Company plc, Cipla Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Recordati S.p.A., Mission Pharmacal Company, DENTAID S.L., Forward Science Holdings LLC, Saliwell Ltd., Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Johnson & Johnson, Colgate-Palmolive Company, Church & Dwight Co. Inc., Prestige Consumer Healthcare Inc., Thornton & Ross Ltd., Roquette FrèresGlobal Artificial Saliva Market Trends and Insights
Major companies are operating in the artificial saliva market, focusing on developing innovative solutions such as poly(hydroxyethyl methacrylate) (pHEMA)–based in-mouth hydrogels to deliver sustained moisture release for individuals with xerostomia. A pHEMA hydrogel is a biocompatible polymer matrix that absorbs synthetic saliva, swells significantly, and gradually releases moisture unlike traditional artificial saliva sprays that provide only short-term lubrication and require frequent reapplication. For instance, in August 2025, a US-based research team led by Debnath, Malandraki, and Boudouris developed a pHEMA artificial-saliva reservoir hydrogel designed to be placed inside the mouth. The hydrogel can expand up to four times its dry volume, stores saliva substitute solutions, releases moisture gradually for several hours, and maintains performance across multiple swelling–release cycles. Additionally, it demonstrated strong biocompatibility and provided more consistent lubrication, making it a promising next-generation alternative for managing chronic dry mouth.What Are Latest Mergers And Acquisitions In The Artificial Saliva Market?
In March 2023, Hologram Sciences, a US-based health tech company, partnered with Haleon to develop personalized wellness products and address consumer health concerns. The strategic collaboration aims to tackle unmet consumer needs in the United States using Haleon's established brands and create new supplement ideas that provide comprehensive, science-backed, personalized solutions. Haleon is a UK-based consumer healthcare company offering innovative, science-backed health solutions, including artificial saliva products that alleviate dry mouth and enhance oral health.Regional Outlook
North America was the largest region in the artificial saliva market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Artificial Saliva Market?
The artificial saliva market consists of sales of sprays, gels, and lozenges. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Artificial Saliva Market Report 2026?
The artificial saliva market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial saliva industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Artificial Saliva Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.51 billion |
| Revenue Forecast In 2035 | $3.97 billion |
| Growth Rate | CAGR of 13.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Distribution Channel, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Pfizer Inc., Viatris Inc., Bausch Health Companies Inc., Perrigo Company plc, Cipla Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Recordati S.p.A., Mission Pharmacal Company, DENTAID S.L., Forward Science Holdings LLC, Saliwell Ltd., Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Johnson & Johnson, Colgate-Palmolive Company, Church & Dwight Co. Inc., Prestige Consumer Healthcare Inc., Thornton & Ross Ltd., Roquette Frères |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
